In our preliminary clinical observation, we found that MMP-12 was highly expressed in CRPC but was hardly expressed in patients with benign prostatic hyperplasia (BPH) and that high expression of MMP-12 was associated with poor pathological stage. Here, MMP12 is linked to benign prostatic hyperplasia.